Fluorescence-navigated Thoracoscopy for Detection of Small Pulmonary Nodules
NCT ID: NCT04165603
Last Updated: 2019-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
352 participants
INTERVENTIONAL
2018-12-18
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fluorescence-navigated Thoracoscopy for Pulmonary Segmentectomy
NCT04160884
Near Infrared Fluorescence Imaging With Indocyanine Green
NCT02851368
Intraoperative Imaging of Thoracic Malignancies With Indocyanine Green
NCT01335893
Technique for Localization of Pulmonary Nodules Using Spy Thoracoscope System
NCT02090660
Minimally Invasive Imagery With Indocyanine Green
NCT02621268
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
5mg/kg of ICG, 24h before surgery
5mg/kg of indocyanine green, intravenously injection 24 hours before surgery
Preoperative Infusion of Indocyanine Green
preoperatively infuse indocyanine green through peripheral vein
1mg/kg of ICG, 24h before surgery
1mg/kg of indocyanine green, intravenously injection 24 hours before surgery
Preoperative Infusion of Indocyanine Green
preoperatively infuse indocyanine green through peripheral vein
5mg/kg of ICG, 48h before surgery
5mg/kg of indocyanine green, intravenously injection 48 hours before surgery
Preoperative Infusion of Indocyanine Green
preoperatively infuse indocyanine green through peripheral vein
1mg/kg of ICG, 48h before surgery
1mg/kg of indocyanine green, intravenously injection 48 hours before surgery
Preoperative Infusion of Indocyanine Green
preoperatively infuse indocyanine green through peripheral vein
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Preoperative Infusion of Indocyanine Green
preoperatively infuse indocyanine green through peripheral vein
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Suitable for surgery and signed informed consent.
Exclusion Criteria
* Allergic to indocyanine green.
* Can't tolerate thoracoscopic surgery.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jun Wang
Chief，Thoracic Surgery Service
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wang Jun, MD
Role: STUDY_DIRECTOR
Peking University People's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University People's Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018PHB144-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.